about
Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401Identifying Recent HIV Infections: From Serological Assays to GenomicsH3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in AfricaHIV-1 subtype C in vitro growth and coreceptor utilization.Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosisIdentification of MHC class II binding peptides: microarray and soluble MHC class II molecules.HIV-1 drug mutations in children from northern TanzaniaMajor histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection.Research capacity. Enabling the genomic revolution in Africa.Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimenWhole CMV proteome pattern recognition analysis after HSCT identifies unique epitope targets associated with the CMV status.High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in BotswanaLong-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.Short communication: phylogenetic characterization of HIV type 1 CRF01_AE V3 envelope sequences in pregnant women in Northern VietnamAnalysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in BotswanaDeciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages.Infant feeding practices were not associated with breast milk HIV-1 RNA levels in a randomized clinical trial in Botswana.Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable.Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.Pairwise diversity and tMRCA as potential markers for HIV infection recencyThe preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites.Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in Botswana.Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.A comparison of flocked swabs and traditional swabs, using multiplex real-time PCR for detection of common gastroenteritis pathogens in Botswana.Using dried blood spots collected under field condition to determine HIV-1 diversity and drug resistance mutations in resource limited Tanzania.Increased CXCR4 use of HIV-1 subtype C identified by population sequencing in patients failing antiretroviral treatment compared with treatment-naive patients in Botswana.The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip.High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.Correction for Novitsky et al., Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.High HIV-1 RNA among Newly Diagnosed People in Botswana.Identification and testing of control peptides for antigen microarrays.
P50
Q24656969-2A65007B-4C9E-4E26-83D3-4CF7F76EF93FQ26778001-2C0BD130-2BDC-4372-B6D7-5170C189C88BQ28601959-E3B59E5E-AEAF-4EA0-9AA3-0FFF08304D1FQ30352511-5A4CAFFF-D53F-4439-895A-E417039D3E19Q31119048-8CF0012B-73EA-41B9-B6B3-C79491F266CCQ33391074-2B3BA44C-0C7B-49EA-802C-EC0EEBB33E0FQ33432025-FBE601F9-DD5C-44C4-949E-70C4CDDD7063Q33746054-C2E4F90F-4AB8-4C71-ABC9-4D3F1196D5C2Q34045503-9A0BB802-57A1-4D59-BB60-C1B3574A5BEBQ34068017-43F9FBD7-3BBB-4F51-A1EB-9792A6EBD462Q34680647-E3318B98-E42A-48AB-8870-4E93C0BB7E5FQ35150820-54261028-B2AC-4676-8435-88A3102EDDA7Q35215399-8FFBCBB3-ED25-44D6-A17A-3BD75BD5B73BQ35744379-4A8679B8-462B-4D67-9971-557160D5B423Q35868716-2788FDDF-875D-4729-B66C-14D53B37F7AAQ36102571-10E0D0A3-D5C2-4B62-9056-AD73DE6492B3Q36110367-4363F981-24C6-4D04-AFAC-8F41DEDB2EF0Q36205668-4B109C7A-56E8-4823-BEC0-5D515DF9209BQ36470674-4453EDB6-F85F-4C47-99E3-C52C172FD11EQ36937881-43D28A46-3BDB-43D8-BC46-2C6779BB4022Q37146865-FED70A61-72CD-4B63-94BE-E08D32D222B0Q37375386-80DC8379-A5C9-4DAD-AA13-6CD1880609B3Q37434357-3DC4D272-F72F-41F7-98DC-F89D60C54020Q37460164-73682DE9-31B6-4F12-9FE3-ACB34A244B16Q37571973-471F8F7D-FB64-4AFA-903C-F8D2E0DC465BQ37646636-96627703-4ED0-4576-BDCB-4A0692D6FFFAQ39141927-09019CFE-7A66-4E53-8CFD-722D36E71B46Q40270394-420A380F-AF5D-44A0-8CA6-A4CB453A84BBQ40354518-104555E4-A310-48F9-A245-FFCC0727C6DFQ40792724-8DBA314A-B8D7-4D32-8686-C7C7D0C21389Q40794656-995C4B92-2013-47FC-9A4B-EEE9858EF382Q40795758-32237C7D-FA27-47AC-A536-35F98B0C7B0AQ40799258-C5FF7610-3EED-4134-B444-51B042786738Q40799743-10E13F89-CF5F-4A76-A7C8-41AD8D0270E7Q40800097-70772CCD-1C3F-472C-9A6B-8E84A54C8740Q42089275-A034B0DF-C054-42E0-84DE-5FB33EC7B3B0Q42698618-1B7676FB-E483-4243-9CF6-E2F3F6E36FD2Q42931814-0E925F00-550A-4BBD-A557-F3E5623F642AQ45305937-F1B3271F-EE70-4491-8BCD-62592B96DA85Q45404965-5A18AEE9-AE2B-4A5A-BBF2-D6F7A84133D9
P50
name
Simani Gaseitsiwe
@en
type
label
Simani Gaseitsiwe
@en
prefLabel
Simani Gaseitsiwe
@en